Drug use in the United Kingdom is among the highest reported in Western Europe and people who inject drugs (PWID) experience stark health inequalities, with increased morbidity and early mortality. This report explores infections, as well as associated risks and behaviours, among people who inject drugs in the UK to the end of 2019. It also presents preliminary data on the impact of COVID-19 on PWID and services in 2020.
Charles Gore: A Call to HCV Action
Charles Gore, Executive Director of the Medicines Patent Pool, and ex CEO of The Hepatitis C Trust, President of the World Hepatitis Alliance and HCV Action steering committee member presents a call to action to hepatitis C practitioners in the UK to share promising practice in hepatitis prevention, diagnosis, treatment and care.
